STEM Wire Oklahoma: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Wire Oklahoma.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 7, 2025

November 7, 2025

CreditBlockchain Empowers BTC, ETH & DOGE Investors with AI-Driven Digital Asset Infrastructure

GlobeNewswire

November 7, 2025

Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025)

GlobeNewswire

November 7, 2025

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

November 7, 2025

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

November 7, 2025

Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

November 7, 2025

TSplus Remote Support 4.3: Faster, Smarter, and More User-Friendly Than Ever

GlobeNewswire

November 7, 2025

BitMart Reframes Digital Asset Yield with the Launch of the Earn Overview Page

GlobeNewswire

November 7, 2025

Spyre Therapeutics Announces Grants of Inducement Awards

GlobeNewswire

November 7, 2025

Surrozen Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

November 7, 2025

Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights

GlobeNewswire

November 7, 2025

BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

November 7, 2025

InflaRx to Announce Topline Data from Phase 2a Clinical Trial of INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria

GlobeNewswire

November 7, 2025

Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week

GlobeNewswire

November 7, 2025

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

November 7, 2025

Exicure, Inc. Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 7, 2025

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

November 7, 2025

Bluepine Tech Foundation Launches Global AI Agricultural Data Service Platform

GlobeNewswire

November 7, 2025

Mayweather’s Money Team Championship Gala: Practice AI™ to Deliver Championship-Level AI Solutions in Personal Injury Cases

GlobeNewswire

November 7, 2025

Mawson Infrastructure Group Inc. Announces Lease Extension For Its Bellefonte, PA Facility

GlobeNewswire

November 7, 2025

Digital Identity and Biometric Solutions Provider BIO-key Hosts Q3 Investor Call Friday, November 14th at 10am ET

GlobeNewswire